MHLW Raises Bar For Generic Usage In Japan To New Heights
This article was originally published in PharmAsia News
Executive Summary
On the heels of missing its March 2013 target for generic usage, Japan’s Ministry of Health, Labor and Welfare issues far-reaching mandate to increase generic prescription rates.
You may also be interested in...
FCPA In The China Framework Warrants Special Attention
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.